vs

Side-by-side financial comparison of Smart Sand, Inc. (SND) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $86.0M, roughly 1.8× Smart Sand, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 1.4%, a 69.8% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -5.8%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $20.4M).

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

SND vs STOK — Head-to-Head

Bigger by revenue
STOK
STOK
1.8× larger
STOK
$158.6M
$86.0M
SND
Growing faster (revenue YoY)
STOK
STOK
+3666.9% gap
STOK
3661.1%
-5.8%
SND
Higher net margin
STOK
STOK
69.8% more per $
STOK
71.2%
1.4%
SND
More free cash flow
STOK
STOK
$111.3M more FCF
STOK
$131.7M
$20.4M
SND

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
SND
SND
STOK
STOK
Revenue
$86.0M
$158.6M
Net Profit
$1.2M
$112.9M
Gross Margin
13.0%
Operating Margin
-3.1%
70.2%
Net Margin
1.4%
71.2%
Revenue YoY
-5.8%
3661.1%
Net Profit YoY
-68.5%
528.0%
EPS (diluted)
$0.03
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SND
SND
STOK
STOK
Q4 25
$86.0M
Q3 25
$92.8M
Q2 25
$85.8M
Q1 25
$65.6M
$158.6M
Q4 24
$91.4M
$22.6M
Q3 24
$63.2M
Q2 24
$73.8M
Q1 24
$83.1M
Net Profit
SND
SND
STOK
STOK
Q4 25
$1.2M
Q3 25
$3.0M
Q2 25
$21.4M
Q1 25
$-24.2M
$112.9M
Q4 24
$3.7M
$-10.5M
Q3 24
$-98.0K
Q2 24
$-430.0K
Q1 24
$-216.0K
Gross Margin
SND
SND
STOK
STOK
Q4 25
13.0%
Q3 25
16.1%
Q2 25
10.4%
Q1 25
4.2%
Q4 24
14.7%
Q3 24
10.3%
Q2 24
17.7%
Q1 24
14.2%
Operating Margin
SND
SND
STOK
STOK
Q4 25
-3.1%
Q3 25
5.8%
Q2 25
-0.1%
Q1 25
-10.8%
70.2%
Q4 24
3.9%
-60.4%
Q3 24
-7.8%
Q2 24
4.8%
Q1 24
0.9%
Net Margin
SND
SND
STOK
STOK
Q4 25
1.4%
Q3 25
3.2%
Q2 25
24.9%
Q1 25
-37.0%
71.2%
Q4 24
4.1%
-46.4%
Q3 24
-0.2%
Q2 24
-0.6%
Q1 24
-0.3%
EPS (diluted)
SND
SND
STOK
STOK
Q4 25
$0.03
Q3 25
$0.08
Q2 25
$0.54
Q1 25
$-0.62
$1.90
Q4 24
$0.10
$-0.15
Q3 24
$0.00
Q2 24
$-0.01
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SND
SND
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$22.6M
$274.8M
Total DebtLower is stronger
$15.0M
Stockholders' EquityBook value
$239.7M
$350.1M
Total Assets
$340.0M
$406.9M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SND
SND
STOK
STOK
Q4 25
$22.6M
Q3 25
$5.1M
Q2 25
$4.3M
Q1 25
$5.1M
$274.8M
Q4 24
$1.6M
$128.0M
Q3 24
$7.2M
Q2 24
$6.3M
Q1 24
$4.6M
Total Debt
SND
SND
STOK
STOK
Q4 25
$15.0M
Q3 25
$14.3M
Q2 25
$23.5M
Q1 25
$13.7M
Q4 24
$14.7M
Q3 24
$15.7M
Q2 24
$17.1M
Q1 24
$25.5M
Stockholders' Equity
SND
SND
STOK
STOK
Q4 25
$239.7M
Q3 25
$239.9M
Q2 25
$240.5M
Q1 25
$219.9M
$350.1M
Q4 24
$243.8M
$229.0M
Q3 24
$243.6M
Q2 24
$242.9M
Q1 24
$242.5M
Total Assets
SND
SND
STOK
STOK
Q4 25
$340.0M
Q3 25
$343.1M
Q2 25
$345.8M
Q1 25
$326.9M
$406.9M
Q4 24
$341.5M
$271.6M
Q3 24
$335.8M
Q2 24
$341.8M
Q1 24
$349.3M
Debt / Equity
SND
SND
STOK
STOK
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.10×
Q1 25
0.06×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SND
SND
STOK
STOK
Operating Cash FlowLast quarter
$22.4M
$131.8M
Free Cash FlowOCF − Capex
$20.4M
$131.7M
FCF MarginFCF / Revenue
23.7%
83.0%
Capex IntensityCapex / Revenue
2.3%
0.1%
Cash ConversionOCF / Net Profit
18.99×
1.17×
TTM Free Cash FlowTrailing 4 quarters
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SND
SND
STOK
STOK
Q4 25
$22.4M
Q3 25
$18.2M
Q2 25
$-5.1M
Q1 25
$8.7M
$131.8M
Q4 24
$1.0M
$-23.2M
Q3 24
$5.8M
Q2 24
$14.9M
Q1 24
$-3.9M
Free Cash Flow
SND
SND
STOK
STOK
Q4 25
$20.4M
Q3 25
$14.8M
Q2 25
$-7.8M
Q1 25
$5.2M
$131.7M
Q4 24
$-840.0K
$-23.2M
Q3 24
$3.7M
Q2 24
$13.5M
Q1 24
$-5.5M
FCF Margin
SND
SND
STOK
STOK
Q4 25
23.7%
Q3 25
15.9%
Q2 25
-9.1%
Q1 25
7.9%
83.0%
Q4 24
-0.9%
-102.7%
Q3 24
5.8%
Q2 24
18.3%
Q1 24
-6.6%
Capex Intensity
SND
SND
STOK
STOK
Q4 25
2.3%
Q3 25
3.6%
Q2 25
3.1%
Q1 25
5.4%
0.1%
Q4 24
2.1%
0.2%
Q3 24
3.4%
Q2 24
1.8%
Q1 24
2.0%
Cash Conversion
SND
SND
STOK
STOK
Q4 25
18.99×
Q3 25
6.05×
Q2 25
-0.24×
Q1 25
1.17×
Q4 24
0.28×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

STOK
STOK

Segment breakdown not available.

Related Comparisons